Active ingredientInsulin GlargineCat. No. P-I050-001CAS 160337-95-1Family · Pharmaceutical analytical standards
Insulin Glargine
A long-acting analogue of human insulin, approved in 2000 in the United States and Europe; injected under the skin, it gradually supplies basal insulin in type 1 and type 2 diabetes. This family brings together the active ingredient and metabolites.
Did you know?Two arginines added to the B chain shift its isoelectric point from pH 5.4 to 6.7: soluble in acidic conditions, under the skin it aggregates and releases insulin slowly, for about 24 hours.
Go to the active ingredient →Active ingredientInsulin GlargineCat. No. P-I050-001CAS 160337-95-1
MetaboliteInsulin Glargine Metabolite 1Cat. No. P-I050-004No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceInsulin glargine CRSEDQM code Y0001542Family Insulin GlargineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.